Choreo LLC Makes New Investment in Koninklijke Philips (NYSE:PHG)

Choreo LLC purchased a new stake in shares of Koninklijke Philips (NYSE:PHG) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 13,150 shares of the technology company’s stock, valued at approximately $330,000.

A number of other large investors also recently modified their holdings of the business. Principal Securities Inc. bought a new position in shares of Koninklijke Philips in the fourth quarter valued at approximately $27,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Koninklijke Philips in the 1st quarter worth approximately $40,000. CWM LLC lifted its position in shares of Koninklijke Philips by 21.9% during the 2nd quarter. CWM LLC now owns 3,429 shares of the technology company’s stock valued at $86,000 after acquiring an additional 616 shares during the last quarter. Blue Trust Inc. increased its stake in Koninklijke Philips by 902.7% in the 2nd quarter. Blue Trust Inc. now owns 3,700 shares of the technology company’s stock worth $93,000 after purchasing an additional 3,331 shares in the last quarter. Finally, Headlands Technologies LLC purchased a new stake in shares of Koninklijke Philips in the 1st quarter valued at approximately $91,000. 13.67% of the stock is owned by institutional investors and hedge funds.

Koninklijke Philips Price Performance

Shares of PHG opened at $31.20 on Wednesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.74 and a current ratio of 1.16. The firm has a market cap of $29.32 billion, a PE ratio of -32.49, a PEG ratio of 1.06 and a beta of 0.73. The firm’s 50 day moving average price is $28.63 and its 200 day moving average price is $25.55. Koninklijke Philips has a twelve month low of $17.75 and a twelve month high of $31.50.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings results on Monday, July 29th. The technology company reported $0.32 earnings per share for the quarter. The business had revenue of $4.80 billion for the quarter. Koninklijke Philips had a negative net margin of 2.35% and a positive return on equity of 10.15%. As a group, research analysts expect that Koninklijke Philips will post 1.5 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Monday, July 15th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.